1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Hua, Q.X.
Nakagawa, S.
Hu, S.Q.
Jia, W.
Weiss, M.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C3 H7 N O3
105.093
D-SERINE
D-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
281
24900
24909
10.1074/jbc.M602691200
16762918
Toward the Active Conformation of Insulin: Stereospecific modulation of a structural switch in the B chain.
2006
10.2210/pdb2hh4/pdb
pdb_00002hh4
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
2383.698
insulin A chain
1
man
polymer
3440.920
insulin B chain
G8(DSN), H10D, P28K, K29P
1
man
polymer
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A
polypeptide(L)
no
yes
FVNQHLC(DSN)SDLVEALYLVCGERGFFYTKPT
FVNQHLCSSDLVEALYLVCGERGFFYTKPT
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
INS
9606
Homo sapiens
562
Escherichia coli
human
Homo
Escherichia
sample
INS
9606
Homo sapiens
562
Escherichia coli
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2006-07-18
1
1
2008-05-01
1
2
2011-07-13
1
3
2021-10-20
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_conn.pdbx_leaving_atom_flag
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2006-06-27
REL
REL
THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR NMR TECHNIQUES.
structures with the lowest energy
40
20
2D TOCSY
NOESY
COSY
7.0
298
K
RMSD VALUES FOR ALL 20 STRUCTURES VERSUS GEOMETRIC AVERAGE: (BACKBONE, A2-A20, B4-B24) 0.51 ANGSTROM
DISTANCE GEOMETRY AND SIMULATED ANNEALING
1
BRUNGER (X-PLOR), BRUNGER (CNS)
refinement
X-PLOR 3.85, CNS
1.1
structure solution
XwinNMR
3.5
700
Bruker
DRX
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
DSN
8
n
8
DSN
8
B
SER
9
n
9
SER
9
B
ASP
10
n
10
ASP
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
LYS
28
n
28
LYS
28
B
PRO
29
n
29
PRO
29
B
THR
30
n
30
THR
30
B
author_defined_assembly
2
dimeric
B
DSN
8
D-SERINE
B
DSN
8
SER
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
B
O
H
ALA
VAL
14
18
1.52
2
B
B
OG1
H
THR
LYS
27
28
1.57
2
B
B
O
H
VAL
TYR
12
16
1.58
3
B
B
O
H
VAL
TYR
12
16
1.51
4
B
B
O
H
GLU
LEU
13
17
1.41
4
B
B
O
H
ALA
VAL
14
18
1.53
5
B
B
HB2
OH
DSN
TYR
8
26
1.08
5
B
B
O
H
ALA
VAL
14
18
1.37
5
B
B
OG
HH
DSN
TYR
8
26
1.38
5
B
B
O
H
LEU
LEU
11
15
1.50
5
B
B
CB
OH
DSN
TYR
8
26
1.94
6
B
B
HB3
HH
DSN
TYR
8
26
1.29
6
B
B
O
H
ALA
VAL
14
18
1.37
6
B
B
O
H
GLU
LEU
13
17
1.54
6
B
B
O
H
LEU
LEU
11
15
1.55
7
B
B
O
H
ALA
VAL
14
18
1.34
8
B
B
O
H
ALA
VAL
14
18
1.49
9
B
B
HB2
HH
DSN
TYR
8
26
1.06
9
A
B
HA
HB2
CYS
CYS
7
7
1.30
9
B
B
O
H
ALA
VAL
14
18
1.32
9
B
B
O
H
GLU
LEU
13
17
1.57
10
B
B
O
H
ALA
VAL
14
18
1.37
10
A
A
O
HG1
GLU
THR
4
8
1.59
10
A
A
O
OG1
GLU
THR
4
8
1.86
11
B
B
O
H
ALA
VAL
14
18
1.57
12
B
B
O
H
ALA
VAL
14
18
1.40
14
B
B
HB2
HH
DSN
TYR
8
26
1.30
14
B
B
HB3
HH
DSN
TYR
8
26
1.34
14
B
B
O
H
ALA
VAL
14
18
1.35
14
B
B
HB3
OH
DSN
TYR
8
26
1.55
16
B
B
O
H
ALA
VAL
14
18
1.47
17
B
B
OG1
H
THR
LYS
27
28
1.46
17
B
B
O
H
VAL
TYR
12
16
1.59
18
B
B
O
H
VAL
TYR
12
16
1.56
19
B
B
O
H
VAL
TYR
12
16
1.59
1
A
GLU
4
-70.30
-104.43
1
A
GLN
5
-39.85
-30.70
1
A
CYS
6
-59.71
-74.92
1
A
SER
9
-141.67
-133.35
1
B
VAL
2
-156.82
-41.10
1
B
GLN
4
-127.51
-159.74
1
B
SER
9
-49.61
-4.50
1
B
PHE
25
-160.99
119.17
1
B
TYR
26
-77.33
-130.68
1
B
THR
27
-79.88
-91.43
1
B
LYS
28
30.57
64.60
1
B
PRO
29
-66.57
91.85
2
A
CYS
6
-90.50
-70.70
2
A
SER
9
173.22
-176.51
2
A
CYS
20
-40.90
166.16
2
B
VAL
2
-79.96
-88.95
2
B
ASN
3
-94.19
-97.16
2
B
GLN
4
-160.79
-27.78
2
B
LEU
6
-160.11
119.47
2
B
SER
9
-39.78
-29.53
2
B
CYS
19
-72.32
-70.43
2
B
THR
27
-40.59
-87.12
2
B
PRO
29
-58.60
-158.41
3
A
CYS
6
-57.58
-77.58
3
A
THR
8
-84.95
-71.90
3
A
SER
9
-117.60
-106.94
3
A
ILE
10
-79.89
-128.28
3
A
CYS
11
179.30
105.81
3
B
CYS
7
179.82
155.79
3
B
CYS
19
-64.61
-76.43
3
B
THR
27
-153.75
-55.71
3
B
LYS
28
59.46
89.07
4
A
VAL
3
-90.68
43.34
4
A
CYS
6
-72.22
-80.52
4
A
CYS
7
-75.95
28.34
4
A
SER
9
-160.06
-80.68
4
B
ASN
3
-145.25
-81.92
4
B
GLN
4
-162.01
-9.32
4
B
HIS
5
-50.67
102.52
4
B
SER
9
-47.69
-10.20
4
B
LEU
15
-36.80
-36.66
4
B
CYS
19
-51.54
-83.00
4
B
ARG
22
179.97
-36.41
4
B
PHE
24
-120.46
-169.29
4
B
PHE
25
-142.26
-99.25
4
B
TYR
26
-164.61
-163.47
5
A
CYS
6
-72.95
-72.13
5
A
SER
9
-156.74
-85.30
5
A
CYS
11
-157.90
-159.17
5
A
CYS
20
-45.35
158.54
5
B
VAL
2
-160.42
-156.50
5
B
DSN
8
39.12
-129.76
5
B
SER
9
-54.59
-1.14
5
B
LEU
15
-37.18
-36.54
5
B
PHE
25
-79.96
-93.62
5
B
TYR
26
-164.18
-79.09
5
B
THR
27
-154.03
-50.30
5
B
LYS
28
57.12
97.74
6
A
GLU
4
-90.24
-72.35
6
A
SER
9
-143.23
-130.62
6
A
CYS
11
-123.31
-142.70
6
A
CYS
20
-20.59
118.28
6
B
ASN
3
172.71
-76.32
6
B
GLN
4
-160.82
-10.94
6
B
SER
9
-55.57
8.38
6
B
LEU
15
-36.63
-31.95
6
B
CYS
19
-62.23
-89.13
6
B
GLU
21
-123.95
-86.20
6
B
PHE
25
-84.89
-85.94
6
B
TYR
26
-163.99
-72.88
6
B
THR
27
-153.47
-74.46
6
B
LYS
28
-150.62
78.80
7
A
SER
9
-154.19
-94.27
7
B
VAL
2
-128.87
-88.12
7
B
SER
9
-55.30
7.42
7
B
ALA
14
-49.56
-70.71
7
B
LEU
15
-37.23
-32.30
7
B
GLU
21
168.67
-32.63
7
B
PHE
25
-85.22
-91.81
7
B
TYR
26
-164.38
-66.51
7
B
THR
27
-146.12
-84.15
7
B
LYS
28
-173.11
57.09
8
A
GLU
4
-83.38
-85.21
8
A
CYS
6
-73.17
-79.66
8
A
SER
9
-162.89
-130.46
8
B
ASN
3
-145.51
52.68
8
B
DSN
8
48.81
-151.92
8
B
SER
9
-52.28
4.13
8
B
PHE
25
-151.06
-94.12
8
B
TYR
26
-164.57
-142.50
8
B
LYS
28
52.75
99.98
9
A
GLU
4
-49.39
-77.16
9
A
GLN
5
-39.69
-34.86
9
A
SER
9
81.88
-164.60
9
A
CYS
11
-126.42
-152.03
9
A
CYS
20
-35.17
114.46
9
B
VAL
2
-159.95
-48.49
9
B
ASN
3
-152.89
-97.15
9
B
GLN
4
-160.84
23.44
9
B
SER
9
-52.44
-2.70
9
B
CYS
19
-82.34
-87.65
9
B
GLU
21
-99.90
-67.87
9
B
ARG
22
-163.98
68.74
9
B
THR
27
-159.79
-81.95
9
B
LYS
28
51.02
71.07
9
B
PRO
29
-68.66
64.25
10
A
VAL
3
-59.33
92.94
10
A
CYS
6
-48.17
-93.43
10
A
THR
8
-82.07
-94.39
10
A
SER
9
-101.30
-124.74
10
B
ASN
3
174.88
60.68
10
B
GLN
4
-159.69
-143.87
10
B
SER
9
-58.16
6.85
10
B
LEU
15
-36.59
-36.26
10
B
CYS
19
-63.01
-75.87
10
B
GLU
21
166.80
60.88
10
B
PHE
25
-160.63
112.31
11
A
ILE
2
-58.99
-94.09
11
A
CYS
7
-66.99
11.12
11
A
SER
9
-152.13
-94.68
11
A
CYS
20
-36.10
149.03
11
B
ASN
3
176.02
40.53
11
B
GLN
4
-145.42
-132.20
11
B
HIS
5
-49.40
102.68
11
B
SER
9
-56.47
5.36
11
B
ASP
10
-91.80
-61.11
11
B
GLU
21
164.88
-31.50
11
B
PHE
24
-110.88
-167.35
11
B
THR
27
-146.21
-69.27
11
B
LYS
28
26.79
-84.68
11
B
PRO
29
-58.10
-165.34
12
A
GLU
4
-86.16
-90.60
12
A
CYS
6
-61.84
-82.80
12
A
SER
9
-165.32
-135.79
12
A
CYS
20
-35.06
112.47
12
B
ASN
3
178.08
-78.00
12
B
GLN
4
-162.05
19.23
12
B
SER
9
-55.00
1.77
12
B
ASP
10
-91.70
-60.42
12
B
LEU
15
-37.38
-36.27
12
B
PHE
25
-160.90
107.13
12
B
TYR
26
-77.31
-145.75
12
B
THR
27
-79.55
-101.31
12
B
LYS
28
43.63
88.31
12
B
PRO
29
-68.64
63.82
13
A
VAL
3
-39.36
88.00
13
A
THR
8
-135.94
-38.86
13
A
SER
9
-145.32
-159.78
13
A
LEU
13
-39.71
-34.88
13
B
ASN
3
-68.04
64.10
13
B
CYS
7
142.22
149.72
13
B
SER
9
-39.64
-32.17
13
B
CYS
19
-65.51
-77.13
13
B
THR
27
161.49
133.15
13
B
LYS
28
-47.18
102.59
13
B
PRO
29
-62.59
-158.80
14
A
ILE
2
-90.24
-74.49
14
A
VAL
3
-90.51
38.34
14
A
SER
9
-139.78
-86.30
14
B
ASN
3
-64.48
97.71
14
B
SER
9
-56.08
2.71
14
B
LEU
15
-36.34
-34.81
14
B
GLU
21
178.81
-40.95
14
B
PHE
25
-143.18
-90.43
14
B
TYR
26
-164.59
-82.24
14
B
THR
27
-145.81
-50.76
14
B
PRO
29
-48.66
92.27
15
A
SER
9
-176.40
-66.88
15
B
CYS
7
171.94
175.45
15
B
CYS
19
-75.98
-77.48
15
B
THR
27
-44.77
-86.52
15
B
LYS
28
-138.74
-68.52
16
A
GLU
4
-90.41
-104.74
16
A
CYS
6
-90.41
-66.92
16
A
SER
9
178.32
-160.49
16
B
VAL
2
-115.49
-154.06
16
B
ASN
3
-50.43
-81.86
16
B
GLN
4
-163.15
-31.93
16
B
HIS
5
-42.79
109.56
16
B
CYS
7
179.16
144.27
16
B
CYS
19
-85.21
-70.63
16
B
TYR
26
-93.72
-75.35
16
B
THR
27
148.85
131.70
16
B
PRO
29
-58.28
106.14
17
A
ILE
2
-89.98
-74.05
17
A
THR
8
-108.74
-104.76
17
A
SER
9
-99.73
-83.51
17
B
GLN
4
-132.89
-151.00
17
B
LEU
6
-151.04
-159.99
17
B
CYS
7
165.50
149.51
17
B
DSN
8
40.20
-152.63
17
B
SER
9
-37.81
-36.73
17
B
THR
27
-86.71
-98.17
18
A
GLU
4
-90.38
-60.13
18
A
CYS
7
-90.79
38.83
18
A
THR
8
-143.47
-47.82
18
A
SER
9
-147.11
-79.43
18
B
ASN
3
-66.97
87.83
18
B
CYS
7
175.16
152.98
18
B
SER
9
-35.21
-34.89
18
B
CYS
19
-60.77
-74.12
18
B
THR
27
173.54
-67.52
18
B
LYS
28
56.69
95.59
18
B
PRO
29
-68.09
89.39
19
A
SER
9
-151.14
-159.77
19
B
CYS
7
-173.48
-175.72
19
B
CYS
19
-68.81
-76.72
19
B
THR
27
-145.61
-118.88
19
B
LYS
28
176.17
64.09
20
A
VAL
3
-90.29
45.13
20
A
THR
8
-113.38
-70.16
20
A
SER
9
-103.40
-160.53
20
A
CYS
11
-113.65
-150.05
20
A
CYS
20
-53.49
177.73
20
B
ASN
3
30.47
-126.50
20
B
GLN
4
-161.02
15.73
20
B
CYS
19
-67.17
-80.37
20
B
THR
27
-49.80
-91.89
20
B
LYS
28
53.92
171.54
20
B
PRO
29
-57.80
108.27
NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures
1
N
N
2
N
N
A
VAL
3
A
VAL
3
HELX_P
A
SER
9
A
SER
9
1
1
7
A
SER
12
A
SER
12
HELX_P
A
CYS
20
A
CYS
20
1
2
9
B
CYS
7
B
CYS
7
HELX_P
B
GLY
20
B
GLY
20
1
3
14
disulf
2.030
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.026
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.028
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
covale
1.329
both
B
CYS
7
B
C
CYS
7
1_555
B
DSN
8
B
N
DSN
8
1_555
covale
1.338
both
B
DSN
8
B
C
DSN
8
1_555
B
SER
9
B
N
SER
9
1_555
HORMONE/GROWTH FACTOR
HORMONE, HUMAN INSULIN, MUTANT, HORMONE-GROWTH FACTOR COMPLEX
Q5EEX2_HUMAN
UNP
1
90
Q5EEX2
GIVEQCCTSICSLYQLENYCN
Q5EEX2_HUMAN
UNP
2
25
Q5EEX2
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
90
110
2HH4
1
21
Q5EEX2
A
1
1
21
25
54
2HH4
1
30
Q5EEX2
B
2
1
30
2
GLY
engineered mutation
DSN
8
2HH4
B
Q5EEX2
UNP
32
8
2
HIS
engineered mutation
ASP
10
2HH4
B
Q5EEX2
UNP
34
10
2
PRO
engineered mutation
LYS
28
2HH4
B
Q5EEX2
UNP
52
28
2
LYS
engineered mutation
PRO
29
2HH4
B
Q5EEX2
UNP
53
29
1
P 1